ENTO

JOIN THE ACTION
Entero Therapeutics Inc. has agreed to merge with Journey Therapeutics Inc. Under the terms of the proposed transaction, Journey shareholders will acquire 99% of the equity of Entero.
Kuehn Law is investigating whether the Board of the target company:‍‍

1) acted to maximize shareholder value
2) failed to disclose material information
3) conducted a fair process

Notice to Shareholders:

Directors' Fiduciary Duties

As shareholders, it's essential to understand the fiduciary duties of the Board of Directors. These duties ensure the Board acts in the best interest of the company and its shareholders.

1. Duty of Care

Diligence: Make informed decisions by thoroughly reviewing information.

Active Participation: Regularly attend and engage in board meetings.

Expert Advice: Seek expert opinions when necessary.

2. Duty of Loyalty

Avoid Conflicts of Interest: Prioritize the company's interests over personal gain.

Self-Dealing: Do not use the position for personal benefit.

Confidentiality: Maintain the confidentiality of company information.

3. Duty of Good Faith

Honesty: Act with integrity in all decisions.

Best Interests: Ensure actions are in the best interest of the company and shareholders.

Fairness: Treat all shareholders fairly and equally.

Your awareness and understanding of these duties are crucial in ensuring the Board acts responsibly and in the best interest of all shareholders.